Kristen Harrington-Smith
Director/Board Member at EFFECTOR THERAPEUTICS, INC.
Net worth: 733 000 $ as of 2024-01-30
Profile
Kristen Harrington-Smith is currently an Independent Director at eFFECTOR Therapeutics, Inc. and the Chief Commercial Officer at ADC Therapeutics SA. Prior to her current roles, she was the Chief Commercial Officer & Senior Vice President at ImmunoGen, Inc. from 2021 to 2022 and the US Commercial Head-Hematology at Novartis Pharmaceuticals from 2020 to 2021.
She received her undergraduate degree from Williams College and her MBA from Kenan-Flagler Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMMUNOGEN, INC.
0.01% | 2022-11-14 | 25,000 ( 0.01% ) | 733 000 $ | 2024-01-30 |
2024-04-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Kristen Harrington-Smith active positions
Companies | Position | Start |
---|---|---|
EFFECTOR THERAPEUTICS, INC. | Director/Board Member | 2022-02-14 |
ADC THERAPEUTICS SA | Corporate Officer/Principal | 2022-11-16 |
Former positions of Kristen Harrington-Smith
Companies | Position | End |
---|---|---|
IMMUNOGEN, INC. | Corporate Officer/Principal | 2022-11-15 |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 2021-10-31 |
Training of Kristen Harrington-Smith
Williams College | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EFFECTOR THERAPEUTICS, INC. | Health Technology |
ADC THERAPEUTICS SA | Health Technology |
Private companies | 2 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Stock Market
- Insiders
- Kristen Harrington-Smith